The TAME Trial

Be a Pioneer in the Next Frontier of Healthy Aging

TAME Nir Barzilai copy 2

AFAR seeks visionary donors to launch the Targeting Aging with Metformin (TAME)Trial.

  • Modern medicine needs an "indication" for aging.
  • With an "indication" for aging, we can target the biology of aging and thereby delay age-related disease.
  • The TAME (Targeting Aging with Metformin) Trial will establish a clinical trial to provide proof-of-concept that aging can be treated, just as we treat diseases.
  • If the TAME Trial is successful, and aging is made an indication for treatment, a new era of treatments will be available. Years of health can be extended; years of sickness, decreased.
TAME Graphics Money Raised Pill

Thank you considering a gift to the TAME Trial below